Merck | MRK - Operating Profit


Merck reported EUR660M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Adidas EUR 1.01B 435M Sep/2026
Adyen EUR 570.31M 56.8M Jun/2026
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 44M 253M Jun/2026
Amadeus IT EUR 527.1M 48.8M Sep/2026
Amarin USD -2.26M 564K Dec/2025
AstraZeneca USD 4.66B 1.5B Sep/2026
BASF EUR -131M 1.57B Sep/2026
Bayer EUR 129M 698M Sep/2026
Beiersdorf EUR 760M 256M Jun/2026
Covestro EUR -324M 5.72B Dec/2025
Danone EUR 1.86B 6M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 153.27M Sep/2026
Genmab DKK 407M 182M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GRIFOLS EUR 394M 65M Sep/2026
Henkel EUR 1.64B 220M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Infineon EUR 866M 260M Sep/2026
Lakefront Biotherapeutics EUR -43.51M 20.19M Jun/2026
Linde USD 2.55B 172M Sep/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 660M 437M Sep/2026
Novartis USD 5.14B 392M Sep/2026
Philips EUR 165M 445M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 2.34B Sep/2026
UCB EUR 1.29B 571M Dec/2025